AriBio Co., a South Korean biopharmaceutical company specialising in neurodegenerative diseases, and a Swiss pharmaceuti...
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has kicked off c...
South Korea-based Samsung Bioepis Co. has entered into a license, development and commercialisation agreement with Nipro...
Iceland-based Alvotech, a global biotech company specialising in the development and manufacture of biosimilar medicines...
Australia-headquartered Telix Pharmaceuticals has established Telix Manufacturing Solutions (TMS) in Yokohama, Japan. Te...
Eisai Co. has announced the launch of Pariet® S”(pharmaceutical requiring guidance), which is highly effective...
French pharmaceutical company Sanofi and Blueprint Medicines Corporation, a US-based, publicly traded biopharmaceutical ...
Asia-Pacific is emerging as a major centre for Global Capability Centres for the Life Sciences and Healthcare industry i...
What are the major plans in store after this acquisition? Is there a phase-wise plan? Following the acquisition, Syngen...
The biopharma job market has been tough, with widespread downsizing and frequent layoffs across big pharma. But the wors...
Singapore-based biopharmaceutical company Specialised Therapeutics (ST) has announced the Australian registration of SKY...
CPHI & PMEC China (June 24-26th) returns to the Shanghai New International Expo Center amid a marked surge in i...
Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Adalvo Limited in the Europe...
Taxis Pharmaceuticals, a US-based clinical stage company at the forefront of developing therapies to treat multidrug-res...
US-based BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, has a...
Shanghai Pharmaceutical Group and Novartis, a global pharmaceutical giant, have officially signed a strategic cooperatio...
Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that Mounjaro (tirzepatide), the inno...
It was a privilege to share BioSpectrum Asia’s vision and editorial focus with AVING News during ICPI Week 2025 in...
